Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191021045175N1Phase 3Completed
Phase 3 trial of dexmedetomidine in postoperative pain, sponsored by Mashhad University of Medical Sciences. Primary endpoint: Duration of analgesia after spinal anesthesia. Started Dec 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191021045175N1.